Rojo EA, Videgaray OF, Pedroza GJ

Idioma: Español
Referencias bibliográficas: 18
Paginas: 182-187
Archivo PDF: 140.91 Kb.

FRAGMENTO

La inmunodeficiencia común variable (ICV) es una enfermedad que se caracteriza por disminución de los niveles séricos de inmunoglobulinas (IgG, IgM, IgA) y mayor susceptibilidad a infecciones. Es una inmunodeficiencia primaria, dentro de éstas es la más común, se estima que hasta la tercera parte de las inmunodeficiencias primarias se deben a la ICV. En los pacientes con ICV han sido descritos varios defectos en los linfocitos T y diversas alteraciones en la diferenciación de los linfocitos B. Afecta por igual a hombres y mujeres, las manifestaciones clínicas principales son infecciones respiratorias recurrentes (senos paranasales, bronquios y pulmones).

REFERENCIAS (EN ESTE ARTÍCULO)

1. Cooper Md, Schroeder Md. Primary immunodeficiency diseases. Fauci AS, Braunwald E, Kasper DL, et al. Principles of Internal Medicine. 17ª : McGraw-Hill Publishing Co. 2008: 2053-2061.

2. Bonilla FA, Geha RS. Update on primary immunodeficiency diseases. J Allergy Clin Immunol 2006; 117: S435.

3. Rosen FS, Cooper MD, Wedgwood RJ. The primary immunodeficiency’s. N Engl J Med 1995; 333(7): 431-40. 

4. Ochs HD et al. Primary immunodeficiency diseases: A Molecular and cellular approach, 2d ed. New York, Oxford University Press, 2006.

5. Wrigth JJ, Wagner DK, Blaese RM, Hagengruber C, Waldmann TA, Fleisher TA. Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features. Blood 1990; 76: 2046-2051.

6. Vorechovsky I, Zetterquist H, Paganelli R et al. Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin Immunol Immunopathol 1995; 77(2): 185-92. 

7. Schaffer FM, Parermos J, Zhu ZB, Berger BO, Cooper MD, Volanakis JE. Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III gene. Proc Natl Acad Sci 1989; 86: 8015-8019.

8. Hoew HS, So AKL, Farrant J, Webster ADB. Common variable immunodeficiency in associated with polymorphic markers in the human major histocompatibility complex. Clin Exp Immunol 1991; 83: 387-390.

9. Hinz CF Jr, Boyer JT. Dysgammaglobulinemia in adult manifested as autoimmune hemolytic anemia. N Engl J Med 1963; 269: 1329-1331.

10. Twomey JJ, Jordan PH, Jarrold T. The syndrome of immunoglobulin deficiency and perniciosus anemia. Am J Med 1969; 47: 340-343.

11. Bates CA, Ellison MC, Lynch DA. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 2004; 114(2): 415-21.

12. Teahon K, Webster AD, Price AB, Weston J, Bjarnason. Studies on the enteropathy associated with primary hypogammaglobulinaemia. Gut 1994; 45: 1230-1237.

13. Sa´adu A, Thomson BJ, Bountiff L, Webster ADB. Lymphotropic viruses in «common variable» immunodeficiency-PCR analysis of lymphocyte DNA for HIV-1 and HHV-6. Clin Exp Immunol 1993; 91: 50-53.

14. Buckley RH. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Ann Rev Immunol 2004; 22: 625.

15. Ballow M. Clinical and investigational considerations for the use of IGIV therapy. Am J Health Syst Pharm 2005; 62(16 Suppl 3): S12-8; quiz S19-21.

16. Orange JS. Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma, and Immunology. J Allergy Clin Immunol 2006; 117: S525.

17. Roifman CM, Schroeder H, Berger M et al. Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial. Int Immunopharmacol 2003; 3(9): 1325-33.

18. Durandy A, Wahn V, Petteway S, Gelfand EW. Immunoglobulin replacement therapy in primary antibody deficiency diseases-maximizing success. Int Arch Allergy Immunol 2005; 136(3): 217-229.